Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Cosmo Daisey who wrote (1533)	4/23/1998 5:45:00 PM
From: Barron Von Hymen	Read Replies (2) \| Respond to of 9523

There are concerns of safety for the women who is having sex with a man who has a penile implant device for his erect.dysfunction. Apparently the implant is a prostaglandin insert, I think PGE2 - I believe VVUS's MUSE is prostaglandin insert. There are concerns that the insert might release prostaglandin into the women's vagina. As far as I know, PGE2 is a nasty prostaglandin, in that it causes bleeding and used to induce uterine contractions. I believe PGE2 is also a major mediator of pain via its actions on neuronal tissue. Perhaps someone can corraborate these facts? Strange, they don't disclose these concerns when they hammer the table with a stock. Of course, Viagra stays in the man's blood stream, and I believe less than 0.01% of dose escapes in the sperm. Much safer for the partner.